Medicare reconsiders non-approved device policy
This article was originally published in Clinica
Executive Summary
Medicare, the US health programme for the elderly, may pay for unapproved medical technologies under certain circumstances. The Health Care Financing Administration (HCFA), which controls Medicare, has been meeting FDA officials to consider its reimbursement policies. A change would be important because FDA delays mean many important devices are routinely used years before they are approved, reports Clinica's Washington correspondent, Duffy Miller.